Receptors for leptin in the otic labyrinth and the cochlear-vestibular nerve of guinea pig are modified in hormone-induced anorexia

Hearing Research

Volumn 270, Issue 1-2, 2010, Pages 48-55

  Horner, Kathleen C ^a   Troadec, Jean Denis ^a   Blanchard, Marie Pierre ^b   Dallaporta, Michel ^a   Pio, Juliette ^a  

^a University of Mediterranée   (France)

^b IFR Jean Roche   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; CONTROLLED STUDY; FEMALE; GUINEA PIG; IMMUNOHISTOCHEMISTRY; INNER EAR; MALE; NONHUMAN; PRIORITY JOURNAL; VESTIBULOCOCHLEAR NERVE;

ANIMALS; ANOREXIA; ASTROCYTES; DISEASE MODELS, ANIMAL; DRUG IMPLANTS; EAR, INNER; ESTRADIOL; FEMALE; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; MALE; NEUROGLIA; RECEPTORS, LEPTIN; VESTIBULOCOCHLEAR NERVE;

EID: 78649895489     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2010.09.009     Document Type: Article

References (80)

1. Ahima R.S., Flier J.S. Leptin. Annu. Rev. Physiol. 2000, 62:413-437.
2. Ahima R.S., Bjorbaek C., Osei S., Flier J.S. Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology 1999, 140:2755-2762.
3. Ahima R.S., Saper C.B., Flier J.S., Elmquist J.K. Leptin regulation of neuroendocrine systems. Front. Neuroendocrinol. 2000, 21:263-307.
4. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J.S. Role of leptin in the neuroendocrine response to fasting. Nature 1996, 382:250-252.
5. Bennett P.A., Lindell K., Karlsson C., Robinson I.C., Carlsson L.M., Carlsson B. Differential expression and regulation of leptin receptor isoforms in the rat brain: effects of fasting and oestrogen. Neuroendocrinology 1998, 67:29-36.
6. Bjorbaek C., Elmquist J.K., Michl P., Ahima R.S., van Bueren A., McCall A.L., Flier J.S. Expression of leptin receptor isoforms in rat brain microvessels. Endocrinology 1998, 139:3485-3491.
7. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
8. Bray G.A., York D.A. The Mona Lisa hypothesis in the time of leptin. Recent Prog. Horm. Res. 1998, 53:95-117. discussion 117-8.
9. Burguera B., Hofbauer L.C., Thomas T., Gori F., Evans G.L., Khosla S., Riggs B.L., Turner R.T. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 2001, 142:3546-3553.
10. Chauveau C., Devedjian J.C., Delecourt C., Jeanfils J., Hardouin P., Broux O. Leptin receptors and beta2-adrenergic receptor mRNA expression in brain injury-related heterotopic ossification. J. Recept. Signal. Transduct. Res. 2008, 28:347-359.
11. Clement-Lacroix P., Ormandy C., Lepescheux L., Ammann P., Damotte D., Goffin V., Bouchard B., Amling M., Gaillard-Kelly M., Binart N., Baron R., Kelly P.A. Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology 1999, 140:96-105.
12. Cornish J., Callon K.E., Bava U., Lin C., Naot D., Hill B.L., Grey A.B., Broom N., Myers D.E., Nicholson G.C., Reid I.R. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 2002, 175:405-415.
13. Dallaporta M., Pecchi E., Pio J., Jean A., Horner K.C., Troadec J.D. Expression of leptin receptor by glial cells of the nucleus tractus solitarius: possible involvement in energy homeostasis. J. Neuroendocrinol. 2009, 21:57-67.
14. De Rosa V., Procaccini C., La Cava A., Chieffi P., Nicoletti G.F., Fontana S., Zappacosta S., Matarese G. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J. Clin. Invest. 2006, 116:447-455.
15. Delaney A.J., Samorajski T., Fuller G.N., Wiggins R.C. A morphometric comparison of central and peripheral hypomyelination induced by postnatal undernourishment of rats. J. Nutr. 1981, 111:746-754.
16. Del-Bigio M.R. Glial linings of the brain. The Neuronal Environment. Brain Homeostasis in Health and Disease 2002, 341-375. Humana Press Inc., Totowa, NJ. W. Walz (Ed.).
17. Devos R., Richards J.G., Campfield L.A., Tartaglia L.A., Guisez Y., van der Heyden J., Travernier J., Plaetinck G., Burn P. OB protein binds specifically to the choroid plexus of mice and rats. Proc. Natl. Acad. Sci. USA 1996, 93:5668-5673.
18. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., Shen J., Vinson C., Rueger J.M., Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100:197-207.
19. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., Kondo H., Richards W.G., Bannon T.W., Noda M., Clement K., Vaisse C., Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
20. Elmquist J.K., Bjorbaek C., Ahima R.S., Flier J.S., Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 1998, 395:535-547.
21. Escobar-Morreale H.F., Escobar del Rey F., Morreale de Escobar G. Thyroid hormones influence serum leptin concentrations in the rat. Endocrinology 1997, 138:4485-4488.
22. Flier J.S., Harris M., Hollenberg A.N. Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. J. Clin. Invest. 2000, 105:859-861.
23. Fraher J.P., Delanty F.J. The development of the central-peripheral transitional zone of the rat cochlear nerve. A light microscopic study. J. Anat. 1987, 155:109-118.
24. Freemark M., Fleenor D., Driscoll P., Binart N., Kelly P. Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 2001, 142:532-537.
25. Grill H.J., Schwartz M.W., Kaplan J.M., Foxhall J.S., Breininger J., Baskin D.G. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 2002, 143:239-246.
26. Gussen R. Malnutrition and deafness. J. Laryngol. Otol. 1974, 88:523-530.
27. Hamrick M.W., Della-Fera M.A., Choi Y.H., Pennington C., Hartzell D., Baile C.A. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J. Bone Miner. Res. 2005, 20:994-1001.
28. Henderson D.C., Doraiswamy P.M. Prolactin-related and metabolic adverse effects of atypical antipsychotic agents. J. Clin. Psychiatry 2008, 69(Suppl. 1):32-44.
29. Hoggard N., Hunter L., Lea R.G., Trayhurn P., Mercer J.G. Ontogeny of the expression of leptin and its receptor in the murine fetus and placenta. Br. J. Nutr. 2000, 83:317-326.
30. Hoggard N., Hunter L., Duncan J.S., Williams L.M., Trayhurn P., Mercer J.G. Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc. Natl. Acad. Sci. USA 1997, 94:11073-11078.
31. Horner K.C. The effect of sex hormones on bone metabolism of the otic capsule-an overview. Hear. Res. 2009, 252:56-60.
32. Horner K.C., Troadec J.D., Dallaporta M., Pio J. Effect of chronic estradiol administration on vimentin and GFAP immunohistochemistry within the inner ear. Neurobiol. Dis. 2009, 35:201-208.
33. Horner K.C., Guieu R., Magnan J., Chays A., Cazals Y. Prolactinoma in some Meniere's patients-is stress involved?. Neuropsychopharmacology 2002, 26:135-138.
34. Horner K.C., Cazals Y., Guieu R., Lenoir M., Sauze N. Experimental estrogen-induced hyperprolactinemia results in bone-related hearing loss in the guinea pig. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1224-E1232.
35. Hsuchou H., Pan W., Barnes M.J., Kastin A.J. Leptin receptor mRNA in rat brain astrocytes. Peptides 2009, 30:2275-2280.
36. Kanzaki S., Ito M., Takada Y., Ogawa K., Matsuo K. Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin. Bone 2006, 39:414-419.
37. Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab. 2006, 4:341-348.
38. Kinney S.E. The metabolic evaluation in Meniere's disease. Otolaryngol. Head Neck Surg. 1980, 88:594-598.
39. Knipper M., Bandtlow C., Gestwa L., Kopschall I., Rohbock K., Wiechers B., Zenner H.P., Zimmermann U. Thyroid hormone affects Schwann cell and oligodendrocyte gene expression at the glial transition zone of the VIIIth nerve prior to cochlea function. Development 1998, 125:3709-3718.
40. Komori T., Morikawa Y., Nanjo K., Senba E. Induction of brain-derived neurotrophic factor by leptin in the ventromedial hypothalamus. Neuroscience 2006, 139:1107-1115.
41. Lanser M.J., Sussman S.A., Frazer K. Epidemiology, pathogenesis, and genetics of acoustic tumors. Otolaryngol. Clin. North Am. 1992, 25:499-520.
42. Lautermann J., Schacht J. Reduced nutritional status enhances ototoxicity. Laryngorhinootologie 1995, 74:724-727.
43. Lee H.S., Kim K.R., Chung W.H., Cho Y.S., Hong S.H. Early sensorineural hearing loss in ob/ob mouse, an animal model of type 2 diabetes. Clin. Exp. Otorhinolaryngol. 2008, 1:211-216.
44. Lee Y.J., Park J.H., Ju S.K., You K.H., Ko J.S., Kim H.M. Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Lett. 2002, 528:43-47.
45. Lynn R.B., Cao G.Y., Considine R.V., Hyde T.M., Caro J.F. Autoradiographic localization of leptin binding in the choroid plexus of ob/ob and db/db mice. Biochem. Biophys. Res. Commun. 1996, 219:884-889.
46. Margetic S., Gazzola C., Pegg G.G., Hill R.A. Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord. 2002, 26:1407-1433.
47. Matarese G., Sanna V., Di Giacomo A., Lord G.M., Howard J.K., Bloom S.R., Lechler R.I., Fontana S., Zappacosta S. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur. J. Immunol. 2001, 31:1324-1332.
48. Matarese G., Carrieri P.B., La Cava A., Perna F., Sanna V., De Rosa V., Aufiero D., Fontana S., Zappacosta S. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2005, 102:5150-5155.
49. Matarese G., Di Giacomo A., Sanna V., Lord G.M., Howard J.K., Di Tuoro A., Bloom S.R., Lechler R.I., Zappacosta S., Fontana S. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol. 2001, 166:5909-5916.
50. Matsuda M., Mori T., Sassa S., Sakamoto S., Park M.K., Kawashima S. Chronic effect of hyperprolactinemia on blood glucose and lipid levels in mice. Life Sci. 1996, 58:1171-1177.
51. Medic-Stojanoska M., Pletikosic I. Disturbances of lipid and lipoprotein metabolism in hypeprolactinemia and acromegaly. Med. Pregl. 2009, 62(Suppl. 3):91-94.
52. Meli R., Pacilio M., Raso G.M., Esposito E., Coppola A., Nasti A., Di Carlo C., Nappi C., Di Carlo R. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 2004, 145:3115-3121.
53. Mellanby E. The experimental production of deafness in young animals by diet. J. Physiol. 1938, 94:380-398.
54. Meltser I., Tahera Y., Simpson E., Hultcrantz M., Charitidi K., Gustafsson J.A., Canlon B. Estrogen receptor beta protects against acoustic trauma in mice. J. Clin. Invest. 2008, 118:1563-1570.
55. Oppenheim D.S., Greenspan S.L., Zervas N.T., Schoenfeld D.A., Klibanski A. Elevated serum lipids in hypogonadal men with and without hyperprolactinemia. Ann. Intern. Med. 1989, 111:288-292.
56. Pacifici R. The immune system and bone. Arch. Biochem. Biophys. 2010, 503:41-53.
57. Pan W., Hsuchou H., He Y., Sakharkar A., Cain C., Yu C., Kastin A.J. Astrocyte leptin receptor (ObR) and leptin transport in adult-onset obese mice. Endocrinology 2008, 149:2798-2806.
58. Pulec J.L. Meniere's disease: results of a two and one-half-year study of etiology, natural history and results of treatment. Laryngoscope 1972, 82:1703-1715.
59. Reseland J.E., Syversen U., Bakke I., Qvigstad G., Eide L.G., Hjertner O., Gordeladze J.O., Drevon C.A. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J. Bone Miner. Res. 2001, 16:1426-1433.
60. Ross M.D., Burkel W. Electron microscopic observations of the nucleus, glial dome, and meninges of the rat acoustic nerve. Am. J. Anat. 1971, 130:73-91.
61. Rybak L.P. Metabolic disorders of the vestibular system. Otolaryngol. Head. Neck. Surg. 1995, 112:128-132.
62. Sherman B.E., Chole R.A. Effect of pharmacological sympathectomy on osteoclastic activity in the gerbilline auditory bulla in vivo. Ann. Otol. Rhinol. Laryngol. 1999, 108:1078-1087.
63. Sherman B.E., Chole R.A. Effect of chemical sympathectomy with 6-hydroxydopamine on osteoclast activity in the gerbilline middle ear bulla. Otol. Neurotol. 2001, 22:237-241.
64. Shi Y., Yadav V.K., Suda N., Liu X.S., Guo X.E., Myers M.G., Karsenty G. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc. Natl. Acad. Sci. USA 2008, 105:20529-20533.
65. Shibata S.B., Cortez S.R., Beyer L.A., Wiler J.A., Di Polo A., Pfingst B.E., Raphael Y. Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp. Neurol. 2010, 223:464-472.
66. Signore A.P., Zhang F., Weng Z., Gao Y., Chen J. Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials. J. Neurochem. 2008, 106:1977-1990.
67. Spencer J.T. Hyperlipoproteinemia, hyperinsulinism, and Meniere's disease. South Med. J. 1981, 74:1194-1197. 1200.
68. Spencer J.T. Metabolic-syndromic sensorineural hearing loss and increased noise vulnerability. Ear Nose Throat J. 2007, 86:314.
69. Stankovic K.M., Adachi O., Tsuji K., Kristiansen A.G., Adams J.C., Rosen V., McKenna M.J. Differences in gene expression between the otic capsule and other bones. Hear. Res. 2010, 265:83-89.
70. Steppan C.M., Crawford D.T., Chidsey-Frink K.L., Ke H., Swick A.G. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul. Pept. 2000, 92:73-78.
71. Takeda S., Karsenty G. Molecular bases of the sympathetic regulation of bone mass. Bone 2008, 42:837-840.
72. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., Armstrong D., Ducy P., Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
73. Thomas T. The complex effects of leptin on bone metabolism through multiple pathways. Curr. Opin. Pharmacol. 2004, 4:295-300.
74. Thomas T., Gori F., Khosla S., Jensen M.D., Burguera B., Riggs B.L. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999, 140:1630-1638.
75. Torossian F., Laredo C. Cochleovestibular disorders and hyperlipidemia. A controlled trial with fenofibrate. Monogr. Atheroscler. 1986, 14:222-229.
76. Ur E. Neuroendocrinology of Leptin 2000, Karger, London.
77. Versini A., Ramoz N., Le Strat Y., Scherag S., Ehrlich S., Boni C., Hinney A., Hebebrand J., Romo L., Guelfi J.D., Gorwood P. Estrogen Receptor 1 Gene (ESR1) is associated with restrictive anorexia nervosa. Neuropsychopharmacology 2010, 35:1818-1825.
78. Young J.K. Anorexia nervosa and estrogen: current status of the hypothesis. Neurosci. Biobehav. Rev. 2010, 34:1195-1200.
79. Zehnder A.F., Kristiansen A.G., Adams J.C., Merchant S.N., McKenna M.J. Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule. Laryngoscope 2005, 115:172-177.
80. Zehnder A.F., Kristiansen A.G., Adams J.C., Kujawa S.G., Merchant S.N., McKenna M.J. Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss. Laryngoscope 2006, 116:201-206.